Location History:
- Ballerup, DK (2004)
- Klampenborg, DK (2003 - 2005)
Company Filing History:
Years Active: 2003-2005
Title: **Innovations of Soren Peter Olesen: A Pioneering Inventor in Pharmacology**
Introduction
Soren Peter Olesen, an accomplished inventor based in Klampenborg, Denmark, has made significant contributions to the field of pharmacology, particularly in the development of potassium channel blocking agents. With a total of four patents to his name, Olesen's research focuses on improving therapeutic options for various diseases through innovative chemical compounds.
Latest Patents
Among Olesen's latest patents is one related to **Potassium Channel Blocking Agents**. This invention encompasses compounds of Formula I, where A and B are linking groups and R, R, R, and R are defined moieties. These compounds serve as potassium channel blocking agents and hold promise for incorporation into pharmaceutical compositions aimed at treating a wide spectrum of diseases. Another notable patent involves **Ion Channel Modulating Agents**. This invention highlights a specific class of chemical compounds represented by general formula (I) that effectively modulate SK, IK, and BK channels. The SK/IK/BK channel modulating agents are not only crucial for designing medicaments but also contribute to pharmaceutical compositions targeting diseases associated with these ion channels.
Career Highlights
Olesen has made his mark in the industry through his tenure at prominent companies like Neurosearch A/S and Sophion Bioscience A/S. His experience at these organizations has contributed to his reputation as an innovator in medical sciences, particularly in the development of therapeutic agents.
Collaborations
Throughout his career, Soren Peter Olesen has collaborated with several notable colleagues, including Palle Christophersen and Lene Teuber. These partnerships have fostered a collaborative environment conducive to innovation and have greatly enhanced the research output in pharmacological development.
Conclusion
Soren Peter Olesen exemplifies the spirit of innovation within the field of pharmacology. His dedication to developing new and effective therapeutic agents through his patents reflects his commitment to advancing medical science. With his work focusing on potassium channel blocking and ion channel modulation, Olesen continues to make strides towards improving treatment options for various diseases, paving the way for future advancements in the industry.